HutchMED (China) LIMITED (HMDCF) Net margin 2016–2025
HutchMED (China) LIMITED (HMDCF) net profit margin by fiscal year — reported net income divided by reported revenue.
83.3%FY2025 · since FY2016: 5.4% → 83.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 83.3% | +77.3 pp |
| FY2024 | 6.0% | -6.0 pp |
| FY2023 | 12.0% | +96.6 pp |
| FY2022 | -84.6% | -30.0 pp |
| FY2021 | -54.7% | +0.5 pp |
| FY2020 | -55.2% | -3.4 pp |
| FY2019 | -51.7% | -16.8 pp |
| FY2018 | -34.9% | -23.9 pp |
| FY2017 | -11.1% | -16.5 pp |
| FY2016 | 5.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More HMDCF financial trends
HMDCF RevenueHMDCF Net incomeHMDCF Gross profitHMDCF Gross marginHMDCF Operating incomeHMDCF Operating marginHMDCF Operating cash flowHMDCF Free cash flowHMDCF Capital expendituresHMDCF Return on equityHMDCF Stock buybacksHMDCF Dividends paidHMDCF Total assetsHMDCF Total liabilitiesHMDCF Shareholders’ equityHMDCF overview →